AAAAAA

   
Results: 1-25 | 26-27
Results: 1-25/27

Authors: Worel, N Greinix, H Ackermann, J Kaufmann, H Urbauer, E Hocker, P Gisslinger, H Lechner, K Kalhs, P Drach, J
Citation: N. Worel et al., Deletion of chromosome 13q14 detected by fluorescence in situ hybridization has prognostic impact on survival after high-dose therapy in patients with multiple myeloma, ANN HEMATOL, 80(6), 2001, pp. 345-348

Authors: Heis-Vahidi-Fard, N Forberg, E Eichinger, S Chott, A Lechner, K Gisslinger, H
Citation: N. Heis-vahidi-fard et al., Ineffectiveness of interferon-gamma in the treatment of idiopathic myelofibrosis: a pilot study, ANN HEMATOL, 80(2), 2001, pp. 79-82

Authors: Neunteufl, T Heher, S Stefenelli, T Pabinger, I Gisslinger, H
Citation: T. Neunteufl et al., Endothelial dysfunction in patients with polycythaemia vera, BR J HAEM, 115(2), 2001, pp. 354-359

Authors: Bachleitner-Hofmann, T Gisslinger, B Grumbeck, E Gisslinger, H
Citation: T. Bachleitner-hofmann et al., Arsenic trioxide and ascorbic acid: synergy with potential implications for the treatment of acute myeloid leukaemia?, BR J HAEM, 112(3), 2001, pp. 783-786

Authors: Gisslinger, H Kurzrock, R Gisslinger, B Jiang, SW Li, SR Virgolini, I Woloszczuk, W Andreeff, M Talpaz, M
Citation: H. Gisslinger et al., Autocrine cell suicide in a Burkitt lymphoma cell line (Daudi) induced by interferon alpha: involvement of tumor necrosis factor as ligand for the CD95 receptor, BLOOD, 97(9), 2001, pp. 2791-2797

Authors: Watzke, IM Millesi, W Kermer, C Gisslinger, H
Citation: Im. Watzke et al., Multifocal eosinophilic granuloma of the jaw: Long-term follow-up of a novel intraosseous corticoid treatment for recalcitrant lesions, ORAL SURG O, 90(3), 2000, pp. 317-322

Authors: Thalhammer-Scherrer, R Geissler, K Schwarzinger, I Chott, A Gisslinger, H Knobl, P Lechner, K Jager, U
Citation: R. Thalhammer-scherrer et al., Fludarabine therapy in Waldenstrom's macroglobulinemia, ANN HEMATOL, 79(10), 2000, pp. 556-559

Authors: Konigsberg, R Ackermann, J Kaufmann, H Zojer, N Urbauer, E Kromer, E Jager, U Gisslinger, H Schreiber, S Heinz, R Ludwig, H Huber, H Drach, J
Citation: R. Konigsberg et al., Deletions of chromosome 13q in monoclonal gammopathy of undetermined significance, LEUKEMIA, 14(11), 2000, pp. 1975-1979

Authors: Konigsberg, R Zojer, N Ackermann, J Kromer, E Kittler, H Fritz, E Kaufmann, H Nosslinger, T Riedl, L Gisslinger, H Jager, U Simonitsch, I Heinz, R Ludwig, H Huber, H Drach, J
Citation: R. Konigsberg et al., Predictive role of interphase cytogenetics for survival of patients with multiple myeloma, J CL ONCOL, 18(4), 2000, pp. 804-812

Authors: Grumbeck, E Aiginger, P Gisslinger, B Geissler, K Thalhammer-Scherrer, R Gisslinger, H
Citation: E. Grumbeck et al., Macrocytic anemia and thrombocytosis associated with thymoma: A case report, AM J HEMAT, 63(1), 2000, pp. 38-41

Authors: Geissler, K Gisslinger, H Knobl, P Sperr, W Valent, P Dieckmann, K Chott, A Potter, R Lechner, K Jager, U
Citation: K. Geissler et al., Efficacy of standard treatment in patients with Hodgkin's disease - A single center experience, WIEN KLIN W, 112(14), 2000, pp. 624-628

Authors: Schreiber, S Ackermann, J Obermair, A Kaufmann, H Urbauer, E Aletaha, K Gisslinger, H Chott, A Huber, H Drach, J
Citation: S. Schreiber et al., Multiple myeloma with deletion of chromosome 13q is characterized by increased bone marrow neovascularization, BR J HAEM, 110(3), 2000, pp. 605-609

Authors: Zojer, N Konigsberg, R Ackermann, J Fritz, E Dallinger, S Kromer, E Kaufmann, H Riedl, L Gisslinger, H Schreiber, S Heinz, R Ludwig, H Huber, H Drach, J
Citation: N. Zojer et al., Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence insitu hybridization, BLOOD, 95(6), 2000, pp. 1925-1930

Authors: Mitterbauer, G Winkler, K Gisslinger, H Geissler, K Lechner, K Mannhalter, C
Citation: G. Mitterbauer et al., Clonality analysis using X-chromosome inactivation at the human androgen receptor gene (HUMARA) - Evaluation of large cohorts of patients with chronic myeloproliferative diseases, secondary neutrophilia, and reactive thrombocytosis, AM J CLIN P, 112(1), 1999, pp. 93-100

Authors: Filipits, M Drach, J Pohl, G Schuster, J Stranzl, T Ackermann, J Konigsberg, R Kaufmann, H Gisslinger, H Huber, H Ludwig, H Pirker, R
Citation: M. Filipits et al., Expression of the lung resistance protein predicts poor outcome in patients with multiple myeloma, CLIN CANC R, 5(9), 1999, pp. 2426-2430

Authors: Fiegl, M Chott, A Seewann, HL Lechner, K Gisslinger, H
Citation: M. Fiegl et al., Persisting bone marrow aplasia following interferon-alpha combined with ara-C for chronic myelogenous leukemia, LEUK LYMPH, 34(1-2), 1999, pp. 191-195

Authors: Meidlinger, P Knobl, P Jager, U Gisslinger, H Pabinger, I Weltermann, A Lechner, K Geissler, K
Citation: P. Meidlinger et al., Granulocyte colony-stimulating factor-supported combined immunosuppressivetherapy (antilymphocyte globulin, cyclosporine, and methylprednisolone) inpatients with aplastic anemia: tolerability, efficacy, and changes in the progenitor cell compartment, ANN HEMATOL, 78(7), 1999, pp. 299-304

Authors: Fiegl, M Weltermann, A Stindl, R Fonatsch, C Lechner, K Gisslinger, H
Citation: M. Fiegl et al., Massive disseminated intravascular coagulation and hyperfibrinolysis in alveolar rhabdomyosarcoma: case report and review of the literature, ANN HEMATOL, 78(7), 1999, pp. 335-338

Authors: Reiter, E Kalhs, P Keil, F Rabitsch, W Gisslinger, H Mayer, G Worel, N Lechner, K Greinix, HT
Citation: E. Reiter et al., Effect of high-dose melphalan and peripheral blood stem cell transplantation on renal function in patients with multiple myeloma and renal insufficiency: a case report and review of the literature, ANN HEMATOL, 78(4), 1999, pp. 189-191

Authors: Bachleitner-Hofmann, T Gisslinger, H
Citation: T. Bachleitner-hofmann et H. Gisslinger, The role of interferon-alpha in the treatment of idiopathic myelofibrosis, ANN HEMATOL, 78(12), 1999, pp. 533-538

Authors: Heis, N Rintelen, C Gisslinger, B Knobl, P Lechner, K Gisslinger, H
Citation: N. Heis et al., The effect of interferon alpha on myeloproliferation and vascular complications in polycythemia vera, EUR J HAEMA, 62(1), 1999, pp. 27-31

Authors: Mayr, N Zeitlhofer, J Deecke, L Fritz, E Ludwig, H Gisslinger, H
Citation: N. Mayr et al., Neurological function during long-term therapy with recombinant interferonalpha, J NEUROP CL, 11(3), 1999, pp. 343-348

Authors: Michiels, JJ Kutti, J Stark, P Bazzan, M Gugliotta, L Marchioli, R Griesshammer, M van Genderen, PJJ Briere, J Kiladjian, JJ Barbui, T Finazzi, G Berlin, NI Pearson, TC Green, AC Fruchtmann, SM Silver, RT Hansmann, E Wehmeier, A Lengfelder, E Landolfi, R Kvasnicka, HM Hasselbalch, H Cervantes, F Reilly, JT Demory, JL Gisslinger, H Guardiola, P Martyre, MC Le Bousse-Kerdiles, MC Thiele, J
Citation: Jj. Michiels et al., Diagnosis, pathogenesis and treatment of the myeloproliferative disorders essential thrombocythemia, polycythemia vera and essential megakaryocytic granulocytic metaplasia and myelofibrosis, NETH J MED, 54(2), 1999, pp. 46-62

Authors: Fureder, W Weltermann, A Chott, A Gisslinger, H Valent, P Jager, U Geissler, K Lechner, K
Citation: W. Fureder et al., Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine), WIEN KLIN W, 111(24), 1999, pp. 1027-1030

Authors: Lechner, K Geissler, K Gisslinger, H
Citation: K. Lechner et al., Polycythaemia vera - Diagnosis and therapy, WIEN KLIN W, 111(15), 1999, pp. 582-589
Risultati: 1-25 | 26-27